Open AccessThis article is
- freely available
Shiga Toxins and the Pathophysiology of Hemolytic Uremic Syndrome in Humans and Animals
Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA 02118, USA
These authors contributed equally to this work.
* Author to whom correspondence should be addressed.
Received: 17 September 2012; in revised form: 1 November 2012 / Accepted: 2 November 2012 / Published: 8 November 2012
Abstract: Food-borne diseases are estimated at 76 million illnesses and 5000 deaths every year in the United States with the greatest burden on young children, the elderly and immunocompromised populations. The impact of efficient food distribution systems and a truly global food supply ensures that outbreaks, previously sporadic and contained locally, are far more widespread and emerging pathogens have far more frequent infection opportunities. Enterohemorrhagic E. coli is an emerging food- and water-borne pathogen family whose Shiga-like toxins induce painful hemorrhagic colitis with potentially lethal complications of hemolytic uremic syndrome (HUS). The clinical manifestations of Shiga toxin-induced HUS overlap with other related syndromes yet molecular mechanisms differ considerably. As discussed herein, understanding these differences and the novel properties of the toxins is imperative for clinical management decisions, design of appropriate animal models, and choices of adjunctive therapeutics. The emergence of new strains with rapidly aggressive virulence makes clinical and research initiatives in this field a high public health priority.
Keywords: Enterohemorrhagic E. coli; Shiga toxins; hemolytic uremic syndrome; animal models
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Mayer, C.L.; Leibowitz, C.S.; Kurosawa, S.; Stearns-Kurosawa, D.J. Shiga Toxins and the Pathophysiology of Hemolytic Uremic Syndrome in Humans and Animals. Toxins 2012, 4, 1261-1287.
Mayer CL, Leibowitz CS, Kurosawa S, Stearns-Kurosawa DJ. Shiga Toxins and the Pathophysiology of Hemolytic Uremic Syndrome in Humans and Animals. Toxins. 2012; 4(11):1261-1287.
Mayer, Chad L.; Leibowitz, Caitlin S.; Kurosawa, Shinichiro; Stearns-Kurosawa, Deborah J. 2012. "Shiga Toxins and the Pathophysiology of Hemolytic Uremic Syndrome in Humans and Animals." Toxins 4, no. 11: 1261-1287.